Block by 5-hydroxytryptamine and apomorphine of recombinant human neuronal nicotinic receptors

European Journal of Pharmacology

Volumn 374, Issue 2, 1999, Pages 293-299

  Nakazawa, Ken ^a   Ohno, Yasuo ^a  

^a NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

Author keywords

5 Hydroxytryptamine; Allosteric modulation; Apomorphine; Human nicotinic receptor

Indexed keywords

ACETYLCHOLINE; APOMORPHINE; ION CHANNEL; NICOTINIC RECEPTOR; RECOMBINANT RECEPTOR; SEROTONIN;

ALLOSTERISM; ANIMAL CELL; ARTICLE; CATECHOLAMINE RELEASE; CONCENTRATION RESPONSE; HUMAN; ION CURRENT; MEMBRANE CURRENT; NONHUMAN; OOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BLOCKING; XENOPUS;

ACETYLCHOLINE; ACTION POTENTIALS; ALLOSTERIC REGULATION; ANIMALS; APOMORPHINE; CLONING, MOLECULAR; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; NEURONS; NICOTINIC ANTAGONISTS; OOCYTES; RECEPTORS, NICOTINIC; RECOMBINANT PROTEINS; SEROTONIN; XENOPUS;

EID: 0033041051     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00325-8     Document Type: Article

References (25)

1. Akasu T., Kotetsu K. 5-Hydroxytryptamine decreases the sensitivity of nicotinic acetylcholine receptor in bull-frog sympathetic ganglion cells. J. Physiol. 380:1986;93-109.
2. Althaus J.S., Decker D.E., von Voigtlander P.F., Buxser S.E. Effects of dopamine agonists on dopamine secretion from PC12 cells: lack of functional autoreceptor activity. Res. Commun. Chem. Pathol. Pharmacol. 72:1991;131-142.
3. Arias H.R. Non-competitive inhibition of nicotinic acetylcholine receptors by endogenous molecules. J. Neurosci. Res. 52:1998;369-379.
4. Artalejo A.R., Garcia A.G., Montiel C., Sanchez-Garcia P. A dopaminergic receptor modulates catecholamine release from the cat adrenal gland. J. Physiol. 362:1985;359-368.
5. Ascher P., Large W.A., Rang H.P. Studies on the mechanism of action of acetylcholine antagonists on rat parasympathetic ganglion cells. J. Physiol. 295:1979;139-170.
6. Buisson B., Bertrand D. Open-channel blockers at the human α4β2 neuronal nicotinic acetylcholine receptor. Mol. Pharmacol. 53:1998;555-563.
7. Chavez-Noriega L.E., Crona J.H., Wahburn M.S., Urrutia A., Elliott K.J., Johnson E.C. Pharmacological characterization of recombinant human neuronal nicotinic acetylcholine receptors hα2β2, hα2β4, hα3β2, hα3β4, hα4β2, hα4β4 and hα7 expressed in Xenopus oocytes. J. Pharmacol. Exp. Ther. 280:1997;346-356.
8. Cross K.M., Foreman R.C., Chad J.E. Enhancement by 5-hydroxytryptamine and analogues of desensitization of neuronal and muscle nicotinic receptors expressed in Xenopus oocytes. Br. J. Pharmacol. 114:1995;1636-1640.
9. García-Colunga, Miledi R. Effects of serotonergic agents on neuronal nicotinic acetylcholine receptors. Proc. Natl. Acad. Sci. U.S.A. 92:1995;2919-2923.
10. Hille, B., 1992a. Structure of channel proteins. In: Ion Channels of Excitable Membranes, 2nd edn. Sinauer, Sunderland, MA, pp. 236-258.
11. Hille, B., 1992b. Structure and function. In: Ion Channels of Excitable Membranes, 2nd edn. Sinauer, Sunderland, MA, pp. 445-471.
12. 2+ permeability, conductance, and gating of human α4β2 nicotinic acetylcholine receptors. J. Neurosci. 17:1997;9035-9047.
13. Li X., Rainnie D.G., McCarley R.W., Greene R.W. Presynaptic nicotinic receptors facilitate monoaminergic transmission. J. Neurosci. 18:1998;1904-1912.
14. Mihailescu S., Palomero-Rivero M., Meade-Huerta P., Maza-Flores A., Drucker-Colin R. Effects of nicotine and mecamylamine on rat dorsal raphe neurons. Eur. J. Pharmacol. 360:1998;31-36.
15. Nakazawa K., Akiyama T., Inoue K. Block by apomorphine of acetylcholine receptor channels expressed in Xenopus oocytes. Eur. J. Pharmacol. 269:1994;375-379.
16. Nakazawa K., Akiyama T., Inoue K. Block by 5-hydroxytryptamine of neuronal acetylcholine receptor channels expressed in Xenopus oocytes. Cell. Mol. Neurobiol. 15:1995;495-500.
17. Olale F., Gerzanich V., Kuryatov A., Wang F., Lindstrom J. Chronic nicotinic exposure differently affects the function of human α3, α4, and α7 neuronal nicotinic receptor subtypes. J. Pharmacol. Exp. Ther. 283:1997;675-683.
18. Palma E., Mileo A.M., Eusebi F., Miledi R. Threonine-for-leucine mutation within domain M2 of the neuronal α7 nicotinic receptor converts 5-hydroxytryptamine from antagonist to agonist. Proc. Natl. Acad. Sci. U.S.A. 93:1996;11231-11235.
19. Sontag J.M., Sanderson P., Klepper M., Aunis D., Takeda K., Bader M.F. Modulation of secretion by dopamine involves decreases in calcium and nicotinic currents in bovine chromaffin cells. J. Physiol. 427:1990;495-517.
20. 1B agonists. Synapse. 1:1987;3-9.
21. Stauderman K.A., Mahaffy L.S., Akong M., Veliçelebi G., Chavez-Noriega L.E., Crona J.H., Johnson E.C., Elliott K.J., Gillespie A., Reid R.T., Adams P., Harpold M.M., Corey-Naeve J. Characterization of human recombinant neuronal nicotinic acetylcholine receptor subunit combinations α2β4, α3β4 and α4β4 stably expressed in HEK293 cells. J. Pharmacol. Exp. Ther. 284:1998;777-789.
22. Tallarida, R.T., Jacob, L.S., 1977. Kinetics of drug-receptor interaction: interpreting dose-response data. In: The Dose-Response Relation in Pharmacology. Springer, New York, NY, pp. 49-84.
23. Vijayaraghavan S., Schmid H.A., Mapp K.S. Serotonin mudulates nicotinic responses of adrenal chromaffin cells. J. Neurochem. 61:1993;324-331.
24. Wonnacott S. Presynaptic nicotinic ACh receptors. Trends Neurosci. 20:1997;92-98.
25. Woodhull A.M. Ionic blockage of sodium channels in nerve. J. Gen. Physiol. 61:1973;687-708.